+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Bronchopulmonary Dysplasia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 125 Pages
  • Global
From
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024 - Product Thumbnail Image

5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene D4 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2024 - Product Thumbnail Image

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Cough in Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032

  • Drug Pipelines
  • January 2024
  • 136 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 106 Pages
  • Global
From
Connective Tissue Disease associated with Interstitial Lung Disease (CTD-ILD) - Market Insights, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Connective Tissue Disease associated with Interstitial Lung Disease (CTD-ILD) - Market Insights, Epidemiology and Market Forecast - 2032

  • Report
  • April 2023
  • 140 Pages
  • Global
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 149 Pages
  • Global
From
Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
LIQ-861 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LIQ-861 Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Tralokinumab Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Tralokinumab Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Lebrikizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lebrikizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Treprostinil sodium Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil sodium Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more